Cargando…
Open-label: the clinical effects of adding cannbidiol to usual care of patients with residual symptoms in the diagnosis of Obsessive Compulsive Disorder
INTRODUCTION: Obsessive-compulsive disorder (OCD) is a heterogeneous and debilitating neuropsychiatric disorder. First-line antidepressants with Selective Serotonin Reuptake Inhibitors (SSRIs) and Clomipramine (a tricyclic antidepressant) are unresponsive or partially responsive in 40% of treated pa...
Autores principales: | De Morais, E. R., Zuardi, A. W. Z. P. W., Guimarães, F. S., Osório, F. L., Hallak, J. E., Sanches, R. F., Crippa, J. A. S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10595832/ http://dx.doi.org/10.1192/j.eurpsy.2023.524 |
Ejemplares similares
-
Open-Label Study of Duloxetine for the Treatment of Obsessive-Compulsive Disorder
por: Dougherty, Darin D., et al.
Publicado: (2015) -
Genetics of obsessive-compulsive disorder
por: Purty, Abhishek, et al.
Publicado: (2019) -
Prevalence of Obsessive-Compulsive Spectrum Disorders in Obsessive-Compulsive Disorder
por: Siddiqui, Mohammad Aleem, et al.
Publicado: (2018) -
Obsessive Compulsive Symptoms, Obsessive Compulsive Disorder and Related Disorders in Idiopathic Parkinson’s Disease
por: Çakıroğlu, E., et al.
Publicado: (2023) -
Epilepsy and obsessive-compulsive disorder
por: Kaplan, Peter W.
Publicado: (2010)